| pubmed-article:19016711 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0014520 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C1413863 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0332237 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C1522168 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C2606129 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0913459 | lld:lifeskim |
| pubmed-article:19016711 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:19016711 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19016711 | pubmed:dateCreated | 2009-1-9 | lld:pubmed |
| pubmed-article:19016711 | pubmed:abstractText | An alternative approach to retinoid therapy is to inhibit the cytochrome P450 (CYP)-mediated catabolism of endogenous all-trans retinoic acid in the skin by applying retinoic acid metabolism blocking agents such as talarozole (R115866). | lld:pubmed |
| pubmed-article:19016711 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19016711 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19016711 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19016711 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19016711 | pubmed:issn | 1365-2133 | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:BorgersMM | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:WoutersLL | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:VahlquistAA | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:TörmäHH | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:ShrootBB | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:CoolsMM | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:HagforsenEE | lld:pubmed |
| pubmed-article:19016711 | pubmed:author | pubmed-author:Pavez LorièEE | lld:pubmed |
| pubmed-article:19016711 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19016711 | pubmed:volume | 160 | lld:pubmed |
| pubmed-article:19016711 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19016711 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19016711 | pubmed:pagination | 26-36 | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:meshHeading | pubmed-meshheading:19016711... | lld:pubmed |
| pubmed-article:19016711 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19016711 | pubmed:articleTitle | Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. | lld:pubmed |
| pubmed-article:19016711 | pubmed:affiliation | Department of Medical Sciences/Dermatology, Uppsala University, SE-751 85 Uppsala, Sweden. | lld:pubmed |
| pubmed-article:19016711 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19016711 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19016711 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19016711 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
